CLBT | Cellebrite DI Ltd. Class ANASDAQCommon stock golden cross and death cross projections, cross tests and history

$12.25
+$0.12 (+0.99%)

Cellebrite DI Ltd. Class A (CLBT) is a NASDAQ-listed common stock that Cruxta has tracked for 50/200 crosses since 2023.

The 50 SMA has sat below the 200 on the daily since Feb 2026, with no cross projected inside the 30 bars Cruxta tracks. On both the daily and the 4-hour, price sits between the 50 and the 200; on the weekly it is below both. On the weekly a death cross is projected within 10 bars.

Timeframe summary

Daily as of 3 Nov 16:00 ET

Price
between the two $12.25 vs 50 $11.54 / 200 $13.35
Projection
No cross projected
Test
No active test
Last cross
Death cross 23 Feb 2026 ยท projected 22 bars out

4-hour as of 3 Nov 16:00 ET

Price
between the two $12.25 vs 50 $11.53 / 200 $12.85
Projection
No cross projected
Test
No active test
Last cross
Death cross 25 Aug 2026 ยท projected 15 bars out

Cross history

11
crosses on record since 2023
5 golden6 death
Full cross history โ†’
CrossedDirectionTimeframeProjectedCross test
25 Aug 2026Death4-hour15 bars outNot tested
2 Jul 2026Golden4-hour6 bars outNot tested
23 Feb 2026Death moderatedaily22 bars outNot tested
27 Jan 2026Death4-hour21 bars outNot tested
12 Nov 2025Golden flatdaily25 bars out4 bar cross test

About CLBT

ExchangeNASDAQ
InstrumentCommon stock
Median $ volume, 60 d$26.3M
4-hour coverageYes, since Oct 2025
History on recordSince 2023
Cap bandmid

Cruxta · 50/200 moving-average crosses on US equities. Recorded crosses are observations. Projected crosses are projections, not advice.